Supplemental material for ADC quantification to classify patients candidate to receive bevacizumab treatment for recurrent glioblastoma

Supplemental Material for ADC quantification to classify patients candidate to receive bevacizumab treatment for recurrent glioblastoma by Beatriz Asenjo García, Félix Navarro Guirado, Fátima Nagib Raya, María Vidal Denis, Francisco Bravo Rodríguez and Pedro Galán Montenegro in Acta Radiologica